Holen Sie sich die Stockscreener-App
28.92
3.60%
-1.08
Handel nachbörslich:
28.60
-0.32
-1.11%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALKS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$30.00
Offen:
$29.88
24-Stunden-Volumen:
1.92M
Relative Volume:
1.11
Marktkapitalisierung:
$4.77B
Einnahmen:
$1.51B
Nettoeinkommen (Verlust:
$333.35M
KGV:
14.83
EPS:
1.95
Netto-Cashflow:
$315.22M
1W Leistung:
-0.03%
1M Leistung:
+8.58%
6M Leistung:
-18.31%
1J Leistung:
+2.34%
1-Tages-Spanne:
$28.77
$29.89
1-Wochen-Bereich:
$28.77
$31.69
52-Wochen-Spanne:
$25.56
$36.45
Alkermes Plc Stock (ALKS) Company Profile
Firmenname
Alkermes Plc
Sektor
Telefon
00-353-1-772-8000
Adresse
CONNAUGHT HOUSE, DUBLIN 4
Vergleichen Sie ALKS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
28.92 | 4.85B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Eingeleitet | Goldman | Buy |
| 2025-06-17 | Hochstufung | UBS | Neutral → Buy |
| 2025-05-28 | Eingeleitet | Needham | Buy |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | Hochstufung | UBS | Sell → Neutral |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-11-05 | Hochstufung | Stifel | Hold → Buy |
| 2024-06-17 | Eingeleitet | TD Cowen | Buy |
| 2024-03-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-20 | Herabstufung | UBS | Neutral → Sell |
| 2023-11-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-24 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-10-17 | Eingeleitet | UBS | Neutral |
| 2022-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-16 | Eingeleitet | Piper Sandler | Neutral |
| 2022-04-22 | Fortgesetzt | Goldman | Buy |
| 2022-04-20 | Eingeleitet | Goldman | Buy |
| 2022-01-27 | Hochstufung | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | Eingeleitet | Citigroup | Neutral |
| 2021-10-07 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-10-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-07-30 | Herabstufung | Goldman | Neutral → Sell |
| 2020-02-14 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-02-06 | Eingeleitet | Mizuho | Neutral |
| 2020-01-31 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-05-31 | Eingeleitet | H.C. Wainwright | Neutral |
| 2019-05-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Herabstufung | Goldman | Neutral → Sell |
| 2018-12-14 | Eingeleitet | Wolfe Research | Underperform |
| 2018-12-13 | Herabstufung | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | Eingeleitet | Piper Jaffray | Neutral |
| 2018-08-07 | Eingeleitet | Stifel | Hold |
| 2018-06-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-05-11 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Alkermes Plc Aktie (ALKS) Neueste Nachrichten
Is Alkermes plc stock technically oversoldGap Up & Safe Entry Zone Identification - khodrobank.com
What analysts say about Alkermes plc stockQuarterly Investment Review & Free High Return Stock Watch Alerts - khodrobank.com
Does Alkermes plc show high probability of rebound2025 Price Targets & Breakout Confirmation Trade Signals - Newser
What machine learning models say about Alkermes plcJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Nanotechnology Drug Delivery Market Outlook (2025-2032) : - openPR.com
Wells Fargo Initiates Alkermes Public at Overweight With $44 Price Target - MarketScreener
Applying sector rotation models to Alkermes plcNew Guidance & Free Safe Entry Trade Signal Reports - Newser
Real time alert setup for Alkermes plc performanceBond Market & AI Driven Stock Movement Reports - Newser
How to integrate Alkermes plc into portfolio analysis toolsPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Will a bounce in Alkermes plc offer an exitQuarterly Market Review & Smart Allocation Stock Tips - Newser
How to use a screener to detect Alkermes plc breakouts2025 Top Gainers & Verified Momentum Stock Alerts - Newser
When is the best time to exit Alkermes plc2025 Market Outlook & Expert Curated Trade Setups - Newser
Identifying reversal signals in Alkermes plcMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
Can swing trading help recover from Alkermes plc lossesPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
Using Bollinger Bands to evaluate Alkermes plcTrade Volume Report & AI Driven Stock Reports - Newser
How cyclical is Alkermes plc’s revenue streamJuly 2025 Weekly Recap & Technical Pattern Based Signals - khodrobank.com
Multi asset correlation models including Alkermes plcLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
Analyzing recovery setups for Alkermes plc investorsWeekly Stock Summary & Daily Stock Trend Reports - Newser
How to track smart money flows in Alkermes plcJuly 2025 Market Mood & Weekly Setup with High ROI Potential - Newser
Does Alkermes plc qualify in momentum factor screening2025 Support & Resistance & Weekly Momentum Picks - Newser
Does Alkermes plc fit your quant trading modelQuarterly Earnings Summary & Low Risk Entry Point Guides - Newser
Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 - Yahoo Finance
Visual trend scoring systems applied to Alkermes plcJuly 2025 Outlook & Reliable Intraday Trade Plans - Newser
How to manage a losing position in Alkermes plcWeekly Volume Report & Risk Managed Investment Strategies - Newser
Can Alkermes plc maintain sales growthWeekly Investment Recap & Reliable Breakout Stock Forecasts - khodrobank.com
Is Alkermes plc a top pick in the sectorCEO Change & Smart Money Movement Tracker - khodrobank.com
How Alkermes plc stock performs during market volatilityWeekly Trade Analysis & Accurate Technical Buy Alerts - Newser
Is Alkermes plc stock undervalued right now2025 Pullback Review & Fast Entry Momentum Alerts - khodrobank.com
Alkermes plc stock trend outlook and recovery pathEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser
Sentiment analysis tools applied to Alkermes plcJuly 2025 WrapUp & Real-Time Market Sentiment Reports - Newser
How to read the order book for Alkermes plcShare Buyback & Fast Gain Stock Tips - Newser
Alkermes plc stock trend forecastExit Point & Weekly Watchlist of Top Performers - Newser
Will Alkermes plc benefit from macro trends2025 Macro Impact & AI Forecasted Stock Moves - Newser
Finanzdaten der Alkermes Plc-Aktie (ALKS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alkermes Plc-Aktie (ALKS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nichols Christian Todd | SVP, Chief Commercial Officer |
Jun 10 '25 |
Sale |
31.09 |
3,334 |
103,654 |
86,208 |
0.69%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):